Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and Clostridioides difficile infection.

Julia E SzymczakBrandi M MullerNikitha Shankar ShakamuriKeith W HamiltonJeffrey S GerberMaryrose Laguio-VilaGhinwa K DumyatiScott K FridkinAlice Y GuhSujan C ReddyEbbing Lautenbachnull null

Published in: Infection control and hospital epidemiology (2020)

Prescribers in this study perceived many advantages to using ESCs and FQs, especially under conditions of time pressure and uncertainty. In making decisions about these drugs, prescribers balance risk and benefit, and they believed that the risk of CDI was acceptable in compared with the risk of undertreatment.

Keyphrases

clostridium difficile
healthcare
primary care
depressive symptoms
physical activity
social support
mental health